Fintel on MSN18h
Leerink Partners Downgrades Lexicon Pharmaceuticals (LXRX)Fintel reports that on March 4, 2025, Leerink Partners downgraded their outlook for Lexicon Pharmaceuticals (NasdaqGS:LXRX) ...
23h
SLN ("Silence" or the "Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, ...
23h
A live audio webcast of the fireside chat can be accessed through the Investors section of the Company’s website at www.mereobiopharma.com/investors. An archived replay of the webcast will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback